{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:55:13Z","timestamp":1767707713217,"version":"3.40.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.euroneuro.2013.11.013","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T17:00:54Z","timestamp":1386176454000},"page":"215-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Twelve months of electronic monitoring (MEMS\u00ae) in the Swedish COAST-study: A comparison of methods for the measurement of adherence in schizophrenia"],"prefix":"10.1016","volume":"24","author":[{"given":"Cecilia","family":"Brain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitta","family":"Sameby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Allerby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0364-2626","authenticated-orcid":false,"given":"Jonas","family":"Eberhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margda","family":"Waern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2013.11.013_bib1","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.4088\/JCP.v67n0715","article-title":"A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia","volume":"67","author":"Ascher-Svanum","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib2","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.euroneuro.2013.09.001","article-title":"Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring MEMS\u00ae in the Swedish COAST-study","volume":"23","author":"Brain","year":"2013","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.psychres.2004.11.002","article-title":"A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia","volume":"133","author":"Byerly","year":"2005","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib4","first-page":"282","article-title":"Noncompliance in community psychiatry: a review of clinical interventions","volume":"42","author":"Chen","year":"1991","journal-title":"Hosp. Community Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4088\/JCP.v68n0601","article-title":"Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia","volume":"68","author":"Cooper","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005053-199901000-00009","article-title":"Enhancing medication compliance for people with serious mental illness","volume":"187","author":"Cramer","year":"1999","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib7","first-page":"325","article-title":"Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia","volume":"26","author":"Diaz","year":"2001","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1176\/appi.ajp.159.1.103","article-title":"Antipsychotic medication adherence: is there a difference between typical and atypical agents?","volume":"159","author":"Dolder","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib9","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib10","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","article-title":"Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice","volume":"21","author":"Farmer","year":"1999","journal-title":"Clin. Ther."},{"issue":"Suppl 2","key":"10.1016\/j.euroneuro.2013.11.013_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4088\/JCP.9096su1cc.04","article-title":"Strategies for improving treatment adherence in schizophrenia and schizoaffective disorder","volume":"71","author":"Goff","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib12","unstructured":"Guy, W., 1976. ECDEU Assessment Manual for Psychopharmacology. In: US Department of Health Education, a.W., Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville. (Ed.)."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4088\/JCP.v69n0110","article-title":"Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia","volume":"69","author":"Hudson","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/wps.20060","article-title":"Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies","volume":"12","author":"Kane","year":"2013","journal-title":"World Psychiatry: Off. J.World Psychiatr. Assoc."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S1461145703003389","article-title":"Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia","volume":"6","author":"Kinon","year":"2003","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature","volume":"63","author":"Lacro","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/08039488.2011.577186","article-title":"Suicides during 7 years among a catchment area cohort of patients with psychoses","volume":"66","author":"Lindstrom","year":"2012","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.psychres.2007.05.001","article-title":"Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity","volume":"157","author":"Nakonezny","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.psychres.2009.05.004","article-title":"Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia","volume":"176","author":"Novick","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4088\/JCP.v63n1206","article-title":"Predictors of noncompliance in patients with schizophrenia","volume":"63","author":"Perkins","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.schres.2006.11.015","article-title":"The use of electronic monitoring (MEMS\u00ae) to evaluate antipsychotic compliance in outpatients with schizophrenia","volume":"90","author":"Remington","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","article-title":"Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder","volume":"56","author":"Robinson","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1176\/appi.ajp.2011.10081224","article-title":"A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia","volume":"168","author":"Tiihonen","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jbtep.2008.02.003","article-title":"Psychosocial and socio-demographic correlates of medication compliance among people with schizophrenia","volume":"40","author":"Tsang","year":"2009","journal-title":"J. Behav. Ther. Exp. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib26","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.4088\/JCP.v67n1008","article-title":"Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review","volume":"67","author":"Valenstein","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib27","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/sj.npp.1301347","article-title":"Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study","volume":"32","author":"van Haren","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1176\/appi.ps.54.5.665","article-title":"Psychopharmacology: perspectives on medication adherence and atypical antipsychotic medications","volume":"54","author":"Velligan","year":"2003","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib31","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/schbul\/sbj075","article-title":"Defining and assessing adherence to oral antipsychotics: a review of the literature","volume":"32","author":"Velligan","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib32","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1176\/appi.ps.58.9.1187","article-title":"Relationships among subjective and objective measures of adherence to oral antipsychotic medications","volume":"58","author":"Velligan","year":"2007","journal-title":"Psychiatr. Serv."},{"issue":"Suppl 4","key":"10.1016\/j.euroneuro.2013.11.013_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4088\/JCP.7090su1cj","article-title":"The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.013_bib28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1023\/A:1025499131905","article-title":"Assessment and treatment selection for \u201crevolving door\u201d inpatients with schizophrenia","volume":"68","author":"Weiden","year":"1997","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib29","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1176\/appi.ps.55.8.886","article-title":"Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia","volume":"55","author":"Weiden","year":"2004","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.schres.2011.11.008","article-title":"Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia","volume":"134","author":"Yang","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2013.11.013_bib35","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1176\/appi.ajp.159.10.1653","article-title":"Interventions to improve medication adherence in schizophrenia","volume":"159","author":"Zygmunt","year":"2002","journal-title":"Am. J. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13003441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13003441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T10:28:41Z","timestamp":1538994521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X13003441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0924977X13003441"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.11.013","relation":{},"ISSN":["0924-977X"],"issn-type":[{"type":"print","value":"0924-977X"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Twelve months of electronic monitoring (MEMS\u00ae) in the Swedish COAST-study: A comparison of methods for the measurement of adherence in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}